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. Interestingly, hBD2 also promotes inflammation by recruiting multiple types 125 of immune cells through interacting with both C-C chemokine receptor type 2 (CCR2) and 6 (CCR6) in 126 vitro 5, 6 . However, the role of hBD2 in itch sensation has not been determined. We therefore investigated 127 whether hBD2 could elicit scratching in wild-type C57BL/6J mice. Strikingly, intradermal injections of 128 hBD2 produced a robust scratching response in wild-type mice in a dose-dependent manner (Fig 1, A-B) .
129
In addition, mBD4, the hBD2 ortholog in mouse, and hBD3 could also elicit scratching in mice although 130 the itch intensity varied among different AMPs (see Fig E1 in 
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Since mast cell-derived histamine is one of the best studied pruritogens, especially in allergic itch, and 154 TRPV1 is the major downstream mediator of histaminergic itch, we asked if mast cells are involved in 155 hBD2-elicited itch by measuring hBD2-induced scratching in mast cell-deficient Kit W-sh "sash" mice. 156
Surprisingly, hBD2 evoked comparable scratching responses between the sash mice and the wild-type 157 mice (Fig 1, E) , suggesting that mast cells are dispensable and histamine might not play an essential role 158 in hBD2-induced itch, which is consistent with clinical observations that psoriatic itch is refractory to oral 159 anti-histamines in more than 80% patients 1, 2 . 160
Since hBD2 receptors CCR2 and CCR6 are abundantly expressed by skin-resident cells 5, 6 , we tested 161 hBD2-elicited scratching in both ccr2 -/-and ccr6 -/-mice. To our surprise, hBD2 induced comparable 162 scratching responses among wild-type, ccr2 -/-and ccr6 -/-mice (Fig 2, A-B (Fig 2, F-H) . Moreover, hBD2 also activated human skin resident myeloid 178 cells, which was nearly abolished by a selective TLR4 antagonist LPS-RS (see Fig E4 in this article's 179
Online Repository at www.jacionline.org). Surprisingly, the classic TLR4 ligand LPS from either E. coli 180 or S. enterica did not evoke significant scratching. Since it is known that itch is constitutively inhibited by 181 pain, we thus tested the effects of intraplantar injections of hBD2 or LPS on mechanical threshold. Indeed, 182
we found that LPS markedly reduced the mechanical threshold while hBD2 had no effect (see Fig E5 in  183 this article's Online Repository at www.jacionline.org), suggesting that LPS signaling pathway is 184 associated with the pain sensation while the stimulation of TLR4 by hBD2 primarily generate itch 185 sensation without inducing pain responses. Taken together, these results provide strong evidence that 186 TLR4 expressed by skin-resident immune cells but not DRG neurons mediates hBD2-induced itch in 187 mice. 188
In conclusion, here we first report that hBD2, which is markedly up-regulated in differentiated 189 keratinocytes of psoriatic patients, promotes itch sensation by activating TLR4-expressing cutaneous 190 immune cells in mice. Our findings suggest that hBD2 could act as a potent endogenous pruritogen, 191 which expands the roles of the antimicrobial beta-defensin family and may also provide new therapeutic 192 targets against psoriatic itch. . All transgenic mice were extensively backcrossed to C57BL/6J for 10 or more generations. Conditional knockout TLR4 in the myeloid cell lineage was generated by mating the LysM-cre mice with Tlr4 f/f mice and wild-type littermates were used as the control in the behavior testing. All mice were housed under a 12 h light/dark cycle with food and water provided ad libitum. All behavioral tests were videotaped from a side angle, and behavioral assessments were done by observers blind to the treatments or genotypes of animals. All experiments were performed in accordance with the guidelines of the National Institutes of Health and the International Association for the Study of Pain, and were approved by the Animal Studies Committee at Washington University School of Medicine.
HEK293T cell culture and transfection. HEK293T cells were grown as a monolayer maintained in DMEM (Life Technologies, Carlsbad, CA, USA), supplemented with 10% FBS (Life Technologies, Carlsbad, CA, USA), 100 units·mL −1 penicillin, and 100 µg·mL −1 streptomycin in a humidified incubator at 37°C with 5% CO 2 . The cells were transiently transfected with cDNAs for mouse TRPV1 (mTRPV1) or human TRPA1 (hTRPA1) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). Following transfection, the cells were maintained in DMEM at 37°C for 24 hours before use.
Fresh isolation of mouse skin-resident cells. Fresh mouse ear skin preparations were cut and separated using forceps and digested in 0.25 mg/ml Liberase TL (Roche, Risch-Rotkreuz, Switzerland) in DMEM media for 90 minutes at 37°C as described E2 . Samples were mashed through 70 µm cell strainers and washed with DMEM media supplemented 10% FBS (Life Technologies, Carlsbad, CA, USA), 100 units/ml penicillin, and 100 µg·mL −1 streptomycin. Single-cell suspensions were used for subsequent Ca 2+ imaging assays.
Isolation and short-term culture of mouse DRG neurons. Mouse spinal columns were removed and placed in ice-cold HBSS; neurons were acutely dissociated and maintained as described E3,4 . In brief, laminectomies were performed and bilateral DRG were dissected out. After removal of connective tissues, DRG were transferred to a 1 mL Ca 2+ /Mg 2+ -free HBSS containing 2 µL saturated NaHCO 3 , 0.35 mg lcysteine and 20 U papain (Worthington, Lakewood, NJ, USA), and incubated at 37°C for 10 min. The suspension of DRG was centrifuged, the supernatant was removed, 1 mL Ca 2+ /Mg 2+ -free HBSS containing 4 mg collagenase type II and 1.25 mg dispase type II (Worthington) was added and incubated at 37°C for 10 min. After digestion, neurons were pelleted, suspended in neurobasal medium containing 2% B-27 supplement, 1% L-glutamine, 100 U·mL −1 penicillin plus 100 µg·mL −1 streptomycin, and 50 ng·mL −1 nerve growth factor, plated on a 12 mm coverslip coated with poly-L-lysine (10 µg·mL −1
) and cultured under a humidified atmosphere of 5% CO 2 /95% air at 37°C for 18-24 hr before use.
Live-cell Ca
2+ imaging on freshly isolated skin-resident cells and DRG neurons. Fura-2-based ratiometric measurement of [Ca 2+ ] i was performed as described previously E5 . Freshly isolated skinresident cells and cultured DRG neurons were loaded with 4 µM Fura-2 AM (Life Technologies, Carlsbad, CA, USA) in culture medium at 37°C for 60 min. Cells were then washed three times and incubated in HBSS at room temperature for 30 min before use. Fluorescence at 340 and 380 nm excitation wavelengths was recorded on an inverted Nikon Ti-E microscope equipped with 340, 360 and 380 nm excitation filter wheels using NIS-Elements imaging software (Nikon Instruments Inc., Melville, NY, USA). Fura-2 ratios (F340/F380) reflecting changes in intracellular Ca 2+ upon stimulation were recorded. Values were obtained from 100-250 cells in time-lapse images from each coverslip. Threshold of activation was defined as 3 standard deviations above the average (∼ 20% above the baseline).
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Whole-cell patch-clamp recordings. Whole-cell patch-clamp recordings were performed using an multiclamp 700B amplifier (Molecular Devices, Sunnyvale, CA, USA) at room temperature (22-24 °C) on the stage of an inverted phase-contrast microscope equipped with a filter set for green fluorescence protein visualization (Nikon Instruments Inc., Melville, NY, USA). Pipettes pulled from borosilicate glass (BF 150-86-10; Sutter Instrument Company, Novato, CA, USA) with a Sutter P-97 pipette puller had resistances of 2-4 MΩ when filled with pipette solution containing 140 mM CsCl, 1 mM MgCl 2 , 0.5 mM EGTA, and 10 mM HEPES with pH 7.3 and 315 mOsm·L −1
. A Ca 2+ -free extracellular solution was used for whole-cell recording to avoid Ca 2+ -dependent desensitization of TRPV1 or TRPA1 containing 140 mM NaCl, 5 mM KCl, 0.5 mM EGTA, 1 mM MgCl 2 , 10 mM glucose, and 10 mM HEPES (pH was adjusted to 7.4 with NaOH, and the osmolarity was adjusted to ≈ 340 mOsm/l with sucrose). The wholecell membrane currents were recorded using voltage ramp from −100 to +100 mV for 500 ms at holding potential of 0 mV. Data were acquired using or Clampex 10 (Molecular Devices, Sunnyvale, CA, USA). Currents were filtered at 2 kHz and digitized at 10 kHz.
Acute itch behavior. Mice were shaved on the nape of the neck two days before assay. On the day of experiment, mice were acclimated for 1 hr by placing each of them individually in the recording chamber followed by intradermal injection of hBD2 to the nape of the neck (50 µl per site). Immediately after the injection, mice were videotaped for 30 min without any person in the recording room. After the recording, the videotapes were played back and the number of scratching bouts towards the injection site was counted by an investigator blinded to the treatment. (n=5 independent repeats); C, Bar charts illustrated that percentage of human skin-resident myeloid derived cells responded to hBD2, hBD2 plus LPS-RS. ****p<0.0001, Student's t test.

SUPPLEMENTARY FIGURE LEGEND
Fig E5
Injection of LPS, a TLR4 ligand, evoked acute pain but not itch sensation. A-B, Intradermal injections of LPS (5 µg and 50 µg) from E. coli and S. enterica into wild-type mice didn't caused significantly scratching responses compared with vehicle control. n=6 for each group. n.s, not significant, ANOVA; C, Time course of changes in Paw withdrawal thresholds in response to von Frey filaments before and at several time points after intraplantar injections of 5 µg hBD2 or LPS from E. coli and S. enterica. n=6 for each group. ***p˂0.001, ****p˂0.0001, n.s, not significant, ANOVA.
